Insulin combined with the DPP-4 inhibitor sitagliptin for diabetes: evaluation study

Trial Profile

Insulin combined with the DPP-4 inhibitor sitagliptin for diabetes: evaluation study

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 16 May 2016

At a glance

  • Drugs Sitagliptin (Primary) ; Insulin
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms I-UNITE
  • Most Recent Events

    • 06 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top